|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBSCO_ocn874173683 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
140222t20122012fr a o 000 0 fre d |
040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d N$T
|d OCLCF
|d YDXCP
|d EBLCP
|d DEBSZ
|d OCLCQ
|d OCLCO
|d OCLCQ
|d QGK
|
019 |
|
|
|a 903611290
|a 923189035
|a 1259192447
|
020 |
|
|
|a 9782742013395
|q (electronic bk.)
|
020 |
|
|
|a 2742013393
|q (electronic bk.)
|
020 |
|
|
|z 9782742008216
|
029 |
1 |
|
|a DEBBG
|b BV043026892
|
029 |
1 |
|
|a DEBSZ
|b 44641686X
|
029 |
1 |
|
|a DEBSZ
|b 449714675
|
035 |
|
|
|a (OCoLC)874173683
|z (OCoLC)903611290
|z (OCoLC)923189035
|z (OCoLC)1259192447
|
050 |
|
4 |
|a QP110.V34
|b .P678 2012eb
|
072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
082 |
0 |
4 |
|a 612.13
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Postel-Vinay, Sophie.
|
245 |
1 |
3 |
|a Le ciblage de la voie du VEGF /
|c Sophie Postel-Vinay, Jean-Charles Soria.
|
264 |
|
1 |
|a Montrouge, France ;
|a Esher, England :
|b John Libbey Eurotext,
|c 2012.
|
264 |
|
4 |
|c ©2012
|
300 |
|
|
|a 1 online resource (112 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Mise au Point,
|x 1264-7527
|
588 |
0 |
|
|a Online resource; title from PDF title page (ebrary, viewed February 22, 2014).
|
505 |
0 |
|
|a ""Le ciblage de la voiedu VEGF""; ""Sommaire""; ""Avant-propos""; ""1 -- La voie du VEGF : les récepteurs au VEGF et leurs ligands""; ""2 -- Agents ciblant le VEGF : modes d�action et efficacité thérapeutique""; ""3 -- Toxicité des antiangiogéniques""; ""4 -- Biomarqueurs""
|
546 |
|
|
|a French.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Vascular endothelial growth factors.
|
650 |
|
0 |
|a Neovascularization inhibitors.
|
650 |
|
2 |
|a Angiogenesis Inhibitors
|
650 |
|
6 |
|a Néovascularisation
|x Inhibiteurs.
|
650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
650 |
|
7 |
|a Neovascularization inhibitors.
|2 fast
|0 (OCoLC)fst01035918
|
650 |
|
7 |
|a Vascular endothelial growth factors.
|2 fast
|0 (OCoLC)fst01200619
|
700 |
1 |
|
|a Soria, Jean-Charles.
|
776 |
0 |
8 |
|i Print version:
|a Postel-Vinay, Sophie.
|t Ciblage de la voie du VEGF.
|d Montrouge, France ; Esher, England : John Libbey Eurotext, ©2012
|h viii, 101 pages
|k Mise au point (John Libbey Eurotext)
|x 1264-7527
|z 9782742008216
|
830 |
|
0 |
|a Mise au point (John Libbey Eurotext)
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=779061
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3317962
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10836908
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 779061
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 11655613
|
994 |
|
|
|a 92
|b IZTAP
|